Trial intelligence / Profile preview

Chlorambucil Maintenance in Advanced B-CLL

NCT00017108Phase 3Unknown

Sponsor
European Organisation for Research and Treatment of Cancer
Start
Mar 2001
Modality
Small Molecules
Countries
7
01

Overview

A Phase 3 trial of chlorambucil in chronic lymphocytic leukemia (CLL), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.

02

Drugs

chlorambucil
03

Conditions

chronic lymphocytic leukemia (CLL)

Beyond the preview

Go deeper on NCT00017108.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00017108.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call